Is Bolt Biotherapeutics, Inc. (BOLT) a Buy, Sell, or Hold?
NASDAQ : BOLT
Bolt Biotherapeutics, Inc. — Institutional Ownership
$3.98 USD
-$0.07 (-1.73%)
- Volume
- 10.33K
- Average Volume
- 25.24K
- Market Capitalization
- $7.65M
- P/E Ratio
- -0.25
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $7.20
- Year Low
- $3.75
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.51
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-26 | NF Investment Holdings Limited | 87486.0 | 4.60% |
| 2026-02-26 | Pivotal bioVenture Partners Fund I, L.P. | 52556.0 | 2.70% |
| 2026-02-26 | Pivotal bioVenture Partners Fund I G.P., L.P. | 52556.0 | 2.70% |
| 2026-02-26 | Nan Fung Life Sciences Holdings Limited | 82486.0 | 4.30% |
| 2026-02-26 | Permwell Management Limited | 5000.0 | 0.30% |
| 2026-02-26 | NFLS Beta Limited | 29930.0 | 1.60% |
| 2026-02-26 | NFLS Platform Holdings Limited | 29930.0 | 1.60% |
| 2026-02-26 | Pivotal Life Sciences Holdings Limited | 52556.0 | 2.70% |
| 2026-02-26 | Pivotal Partners Ltd | 52556.0 | 2.70% |
| 2026-02-26 | Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 52556.0 | 2.70% |
| 2026-02-26 | Nan Fung Group Holdings Limited | 87486.0 | 4.60% |
| 2026-02-17 | Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 78445.0 | 4.10% |
| 2026-02-17 | Pivotal Partners Ltd | 78445.0 | 4.10% |
| 2026-02-17 | Pivotal Life Sciences Holdings Limited | 78445.0 | 4.10% |
| 2026-02-17 | Nan Fung Life Sciences Holdings Limited | 123.12K | 6.40% |
| 2026-02-17 | Permwell Management Limited | 5000.0 | 0.30% |
| 2026-02-17 | NFLS Beta Limited | 44674.0 | 2.30% |
| 2026-02-17 | NFLS Platform Holdings Limited | 44674.0 | 2.30% |
| 2026-02-17 | Nan Fung Group Holdings Limited | 128.12K | 6.70% |
| 2026-02-17 | NF Investment Holdings Limited | 128.12K | 6.70% |
| 2026-02-17 | Pivotal bioVenture Partners Fund I, L.P. | 78445.0 | 4.10% |
| 2026-02-17 | Pivotal bioVenture Partners Fund I G.P., L.P. | 78445.0 | 4.10% |
| 2026-02-13 | Vivo Capital Fund VIII, L.P. | - | 0.00% |
| 2025-11-14 | TANG CAPITAL MANAGEMENT, LLC | 66879.0 | 3.50% |
| 2025-11-14 | TANG CAPITAL MANAGEMENT, LLC | 66879.0 | 3.50% |
| 2025-08-14 | TANG CAPITAL MANAGEMENT, LLC | 166.88K | 8.70% |
| 2025-05-15 | TANG CAPITAL MANAGEMENT, LLC | 3.81M | 9.90% |
| 2021-11-29 | Aaron Cowen | 2.23M | 6.00% |
| 2021-11-29 | Averill Master Fund, Ltd. | 2.23M | 6.00% |
| 2021-11-29 | Suvretta Capital Management, LLC | 2.23M | 6.00% |
| 2021-04-07 | RA Capital Healthcare Fund, L.P. | 1.92M | 5.30% |
| 2021-04-07 | Peter Kolchinsky | 2.38M | 6.50% |
| 2021-04-07 | RA Capital Management, L.P. | 2.38M | 6.50% |
| 2021-04-07 | Rajeev Shah | 2.38M | 6.50% |
| 2021-02-19 | Citadel Securities LLC | 10.0 | 12.00% |
| 2021-02-19 | Citadel Advisors LLC | 10.0 | 8.10% |
| 2021-02-19 | Citadel Advisors Holdings LP | 10.0 | 8.10% |
| 2021-02-19 | Citadel GP LLC | 10.0 | 8.10% |
| 2021-02-19 | CALC IV LP | 10.0 | 12.00% |
| 2021-02-19 | Kenneth Griffin | 10.0 | 8.10% |
| 2021-02-19 | Citadel Securities GP LLC | 10.0 | 12.00% |
| 2021-02-18 | Vivo Opportunity, LLC | 150K | 0.40% |
| 2021-02-18 | Vivo Capital VIII, LLC | 2.27M | 6.60% |
| 2021-02-18 | Vivo Panda, LLC | 1.45M | 4.20% |
| 2021-02-17 | Pivotal bioVenture Partners Fund I G.P., L.P. | 1.89M | 5.50% |
| 2021-02-17 | Pivotal bioVenture Partners Fund I U.G.P., Ltd. | 1.89M | 5.50% |
| 2021-02-17 | Pivotal bioVenture Partners Fund I, L.P. | 1.89M | 5.50% |
| 2021-02-16 | Dr. Maha Katabi (“Katabi”) | 2.75M | 8.00% |
| 2021-02-16 | Dr. James I. Healy (“Healy”) | 2.75M | 8.00% |
| 2021-02-16 | Sofinnova Venture Partners X, L.P. (“SVP X”) | 2.75M | 8.00% |
| 2021-02-16 | Sofinnova Management X, L.L.C. (“SM X”) | 2.75M | 8.00% |
| 2021-02-16 | Dr. Michael F. Powell (“Powell”) | 2.75M | 8.00% |
| 2021-02-11 | Novo Holdings A/S | 4.5M | 13.00% |
BOLT Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.47 | 1.87M | $10.23M | $11.7M | $22.96M | $21.48M |
| 2024-12-31 | $10.70 | 1.91M | $20.43M | $7.2M | $25.21M | $38.43M |
| 2023-12-31 | $22.40 | 1.89M | $42.35M | $10.81M | $20.22M | $51.76M |
| 2022-12-31 | $26.00 | 1.87M | $48.57M | $9.24M | $22.61M | $61.93M |
| 2021-12-31 | $98.00 | 1.87M | $183.26M | $27.38M | $24.36M | $180.23M |
| 2020-12-31 | $643.00 | 1.81M | $1.17B | $5.54M | $10.88M | $1.17B |
| 2019-12-31 | $643.00 | 400.5K | $257.52M | $34.83M | $10.18M | $232.88M |
| 2018-12-31 | $643.00 | 97185 | $62.49M | $13.63M | $40000 | $48.9M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4.04 | 1.87M | $7.55M | $11.61M | $22.31M | $18.25M |
| 2025-12-31 | $5.47 | 1.87M | $10.23M | $11.7M | $22.96M | $21.48M |
| 2025-09-30 | $5.32 | 1.92M | $10.21M | $17.75M | $23.59M | $16.05M |
| 2025-06-30 | $5.77 | 1.92M | $11.06M | $9.6M | $24.18M | $25.65M |
| 2025-03-31 | $8.00 | 1.92M | $15.34M | $8.39M | $24.71M | $31.65M |
| 2024-12-31 | $10.70 | 1.91M | $20.48M | $7.2M | $25.21M | $38.49M |
| 2024-09-30 | $12.96 | 1.91M | $24.79M | $9.37M | $18.18M | $33.6M |
| 2024-06-30 | $14.64 | 1.91M | $27.91M | $6.2M | $18.89M | $40.6M |
| 2024-03-31 | $30.00 | 1.9M | $57.1M | $4.26M | $19.57M | $72.41M |
| 2023-12-31 | $22.40 | 1.9M | $42.49M | $10.81M | $20.22M | $51.9M |
| 2023-09-30 | $20.80 | 1.89M | $39.38M | $9.16M | $20.86M | $51.08M |
| 2023-06-30 | $25.60 | 1.89M | $48.32M | $13.45M | $21.47M | $56.34M |